These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 8862498

  • 1. Value of buserelin testing in the evaluation of hirsute women.
    Ambrosi B, Re T, Passini E, Bochicchio D, Ferrario R.
    J Endocrinol Invest; 1996 Apr; 19(4):204-9. PubMed ID: 8862498
    [Abstract] [Full Text] [Related]

  • 2. Comparison between buserelin and dexamethasone testing in the assessment of hirsutism.
    Re T, Barbetta L, Dall'Asta C, Faglia G, Ambrosi B.
    J Endocrinol Invest; 2002 Jan; 25(1):84-90. PubMed ID: 11883870
    [Abstract] [Full Text] [Related]

  • 3. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?
    Escobar-Morreale HF, Serrano-Gotarredona J, García-Robles R, Sancho J, Varela C.
    Metabolism; 1997 Aug; 46(8):902-7. PubMed ID: 9258272
    [Abstract] [Full Text] [Related]

  • 4. Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency.
    Barnes RB, Ehrmann DA, Brigell DF, Rosenfield RL.
    J Clin Endocrinol Metab; 1993 Feb; 76(2):450-5. PubMed ID: 8381802
    [Abstract] [Full Text] [Related]

  • 5. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
    Pasquali R, Patton L, Pocognoli P, Cognigni GE, Gambineri A.
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4208-17. PubMed ID: 17785360
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Ghizzoni L, Virdis R, Vottero A, Cappa M, Street ME, Zampolli M, Ibañez L, Bernasconi S.
    J Clin Endocrinol Metab; 1996 Feb; 81(2):601-6. PubMed ID: 8636275
    [Abstract] [Full Text] [Related]

  • 9. Hyperandrogenic eumenorrheic NON-PCOS women versus women with PCOS after the GnRH-agonist stimulation test preceded by suppression of adrenal steroidogenesis with dexamethasone.
    Benvenga S, Russo M, Forte G, Unfer V.
    J Clin Transl Endocrinol; 2024 Sep; 37():100368. PubMed ID: 39308767
    [Abstract] [Full Text] [Related]

  • 10. Modified dexamethasone and gonadotropin-releasing hormone agonist (Dx-GnRHa) test in the evaluation of androgen source(s) in hirsute women.
    Bidzińska B, Tworowska U, Demissie M, Milewicz A.
    Przegl Lek; 2000 Sep; 57(7-8):393-6. PubMed ID: 11109312
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The prevalence of late onset congenital adrenal hyperplasia in hirsute women from Central Anatolia.
    Kamel N, Tonyukuk V, Emral R, Corapçioğlu D, Baştemir M, Güllü S.
    Endocr J; 2003 Dec; 50(6):815-23. PubMed ID: 14709856
    [Abstract] [Full Text] [Related]

  • 13. Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism.
    Knochenhauer ES, Cortet-Rudelli C, Cunnigham RD, Conway-Myers BA, Dewailly D, Azziz R.
    J Clin Endocrinol Metab; 1997 Feb; 82(2):479-85. PubMed ID: 9024240
    [Abstract] [Full Text] [Related]

  • 14. Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome.
    White D, Leigh A, Wilson C, Donaldson A, Franks S.
    Clin Endocrinol (Oxf); 1995 May; 42(5):475-81. PubMed ID: 7621565
    [Abstract] [Full Text] [Related]

  • 15. ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism.
    Siegel SF, Finegold DN, Lanes R, Lee PA.
    N Engl J Med; 1990 Sep 27; 323(13):849-54. PubMed ID: 2168515
    [Abstract] [Full Text] [Related]

  • 16. On the origin of the elevated 17-hydroxyprogesterone levels after adrenal stimulation in hyperandrogenism.
    Azziz R, Rafi A, Smith BR, Bradley EL, Zacur HA.
    J Clin Endocrinol Metab; 1990 Feb 27; 70(2):431-6. PubMed ID: 2137133
    [Abstract] [Full Text] [Related]

  • 17. Functional hyperandrogenism detected by corticotropin and GnRH-analogue stimulation tests in women affected by apparently idiopathic hirsutism.
    Rossi R, Tauchmanovà L, Luciano A, Valentino R, Savastano S, Battista C, Di Martino M, Lombardi G.
    J Endocrinol Invest; 2001 Feb 27; 24(7):491-8. PubMed ID: 11508782
    [Abstract] [Full Text] [Related]

  • 18. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
    Markopoulos MC, Rizos D, Valsamakis G, Deligeoroglou E, Grigoriou O, Chrousos GP, Creatsas G, Mastorakos G.
    J Clin Endocrinol Metab; 2011 Mar 27; 96(3):623-31. PubMed ID: 21177795
    [Abstract] [Full Text] [Related]

  • 19. Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism.
    Rosenfield RL, Barnes RB, Ehrmann DA.
    J Clin Endocrinol Metab; 1994 Dec 27; 79(6):1686-92. PubMed ID: 7989476
    [Abstract] [Full Text] [Related]

  • 20. A comparison between the effects of low dose (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal P450c17alpha enzyme activity in women with polycystic ovary syndrome.
    Colak R, Keleştimur F, Unlühizarci K, Bayram F, Sahin Y, Tutuş A.
    Eur J Endocrinol; 2002 Oct 27; 147(4):473-7. PubMed ID: 12370108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.